About NAMA CRO

Our strategic Alignment with vision 2030

NAMA CRO was established in 2023 as a Saudi CRO specialized in Medical Writing and Bioequivalence services, and expanded in 2024 to be a regional CRO specialized in RWE clinical trials and providing full set of CRO services.

We have strategically aligned our operations with the Vision 2030 directives, emphasizing affordable and accessible healthcare. By leveraging cutting-edge technology, industry expertise, and strategic partnerships.

Our Trusted Partners

Vision & Mission

What ignites our drive to move forward?

What ignites our drive to
move forward?

Vision: To lead the way in the clinical and pharmaceutical research fostering industrial innovation and engagement.

Mission: To provide smart and innovative clinical research solutions to research community creating the framework necessary for R&D to flourish by creativity and innovation.

150+

Research Projects

2,000+

Publications

15+

Expert team experience

CEO Message

“This is my goal, my vision for NAMA CRO, to help healthcare entities compile as detailed, extensive and complex data as possible in all aspects so it may be used for any purpose, from pharmaceutical advancements to increased diseases detection and prolonged overall health span.”